![]() |
|
|
Forward to a colleague |
||
Product Presentation ![]() CyBio has introduced an innovative enhancement in simultaneous pipetting, two new exchangeable modules for Nanoliter parallel pipetting further extending the broad range of applications of the proven CyBio®:-Well vario pipetting platform... Click Here Access Full Stories Serenex is turning the world of drug discovery inside out by first finding an effective drug candidate and then working out what its target is... Read Zebrafish used to catch heart data A contract research organisation (CRO) is offering a unique toxicity screening service using zebrafish as a model for assessing drug effects on cardiac function... Read Millipore targets arthritis research efficiency Millipore has released a new kit that allows researchers to quickly generate arthritis mouse models for screening and evaluating anti-inflammatory therapeutics... Read Eli Lilly opens door for next-generation antipsychotics Positive results from a Phase II trial have shown that Eli Lilly's latest antipsychotic drug acts on a new target and avoids key adverse effects caused by other antipsychotics... Read Entelos snaps up Iconix, adds safety to efficacy prediction Entelos has decided to upgrade its computational models that predict drug responses in 'virtual patients' by snapping up a toxicology specialist... Read |
||||||||||
All News Headlines for: September | August | July |
||||||||||
![]() A revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here |
||||||||||
|
Related Industry News Dow extracts the stress from bioprocessing US researchers have shown certain organic solvents can be used to selectively extract therapeutic proteins from host bacteria, avoiding the need for cell lysis and increasing product purity by a factor of five... Read South African Enaleni to reopen plant The end of the tunnel seems to be getting closer for South African manufacturer Enaleni as the firm confirmed it will resume production in its recently closed Durban facility in the next ten days... Read Six-month prostate cancer drug soon to be launched A six-month formulation of a prostate cancer drug will soon be launched in 23 European countries following its successful approval procedure... Read eClinical news in brief Outsourcing-Pharma tracks the latest eClinical movements, featuring Phase Forward, Medidata and ICON... Read
|
||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||